Wonbiogen Co Ltd
KOSDAQ:307280
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
IDEXX Laboratories Inc
LSE:0J8P
|
US |
Wonbiogen Co Ltd
Total Equity
Wonbiogen Co Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
W
|
Wonbiogen Co Ltd
KOSDAQ:307280
|
Total Equity
₩41.5B
|
CAGR 3-Years
16%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Total Equity
₩315.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Total Equity
₩553B
|
CAGR 3-Years
34%
|
CAGR 5-Years
35%
|
CAGR 10-Years
49%
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Total Equity
₩126.8B
|
CAGR 3-Years
129%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Total Equity
₩88.8B
|
CAGR 3-Years
50%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Total Equity
₩21.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Wonbiogen Co Ltd
Glance View
Wonbiogen Co., Ltd. engages in the research and development of biocompatible medical materials. The company is headquartered in Gumi, Gyeongsangbuk-Do. The company went IPO on 2018-12-05. The firm provides medical products including dressing material used for lower leg ulcers, pressure ulcers and surgical wounds; dressing material for secretions absorption and wound area protection; fixing band for bandages, gauze, catheters, along with others.
See Also
What is Wonbiogen Co Ltd's Total Equity?
Total Equity
41.5B
KRW
Based on the financial report for Sep 30, 2025, Wonbiogen Co Ltd's Total Equity amounts to 41.5B KRW.
What is Wonbiogen Co Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
44%
Over the last year, the Total Equity growth was 17%. The average annual Total Equity growth rates for Wonbiogen Co Ltd have been 16% over the past three years , 44% over the past five years .
